The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate
Open accessAbstract
An acute increase in the international normalized ratio (INR; a comparison of prothrombin time to monitor the effects of warfarin) over 3 in patients with chronic kidney disease (CKD) is often associated with an unexplained acute increase in serum creatinine (SC) and an accelerated progression of CKD. Kidney biopsy in a subset of these patients showed obstruction of the renal tubule by red blood cell casts, and this appears to be the dominant mechanism of the acute kidney injury. We termed this warfarin-related nephropathy (WRN), and previously reported cases of WRN only in patients with CKD. We now assess whether this occurs in patients without CKD, its risk factors, and consequences. In 15,258 patients who initiated warfarin therapy during a 5-year period, 4006 had an INR over 3 and SC measured at the same time; however, the large data set precluded individual patient clinical assessment. A presumptive diagnosis of WRN was made if the SC increased by over 0.3 mg/dl within 1 week after the INR exceeded 3 with no record of hemorrhage. WRN occurred in 20.5% of the entire cohort, 33.0% of the CKD cohort, and 16.5% of the no-CKD cohort. Other risk factors included age, diabetes mellitus, hypertension, and cardiovascular disease. The 1-year mortality was 31.1% with compared with 18.9% without WRN, an increased risk of 65%. Thus, WRN may be a common complication of warfarin therapy in high-risk patients and CKD doubles this risk. The mechanisms of these risks are unclear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,048
Survival Analysis, Techniques for Censored and Truncated Data
Rao, M. B. (1998) · Technometrics · doi:10.1080/00401706.1998.10485206 · Cited by 3,617
Bleeding Complications With Warfarin Use: A Prevalent Adverse Effect Resulting in Regulatory Action
Wysowski, D. K., Nourjah, P., & Swartz, L. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.13.1414 · Cited by 547
Chan, K. E., Lazarus, J. M., Thadhani, R., & Hakim, R. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009030319 · Cited by 431
Survival Analysis: Techniques for Censored and Truncated Data
Langner, I. (2006) · Biometrics · doi:10.1111/j.1541-0420.2006.00589_9.x · Cited by 346
Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications
Limdi, N. A., Beasley, T. M., Baird, M. F., Goldstein, J. A., McGwin, G., Arnett, D. K., Acton, R. T., & Allon, M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070802 · Cited by 292
Brodsky, S. V., Satoskar, A., Chen, J., Nadasdy, G., Eagen, J. W., Hamirani, M., Hebert, L., Calomeni, E., & Nadasdy, T. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.04.024 · Cited by 236
Self-citationAnticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients
Chan, K. E., Lazarus, J. M., Thadhani, R., & Hakim, R. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080824 · Cited by 200
Continuous quality improvement: DOQI becomes K/DOQI and is updated
Eknoyan, G., Levin, N. W., Eschbach, J. W., Golper, T. A., Owen, W. F., Schwab, S., & Steinberg, E. P. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80074-3 · Cited by 88
Warfarin‐induced allergic interstitial nephritis and leucocytoclastic vasculitis
Kapoor, K., & Bekaii‐Saab, T. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01646.x · Cited by 49
Gas6, warfarin, and kidney diseases
Yanagita, M. (2004) · Clinical and Experimental Nephrology · doi:10.1007/s10157-004-0305-z · Cited by 47
Cited by
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Self-citationSteffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
Regulated cell death pathways in kidney disease
Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., & Ortiz, A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00694-0 · Cited by 393
Turakhia, M. P., Blankestijn, P. J., Carrero, J.-J., Clase, C. M., Deo, R., Herzog, C. A., Kasner, S. E., Passman, R. S., Pecoits-Filho, R., Reinecke, H., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy060 · Cited by 288
Fauchier, L., Boriani, G., de Groot, J. R., Kreutz, R., Rossing, P., & Camm, A. J. (2021) · EP Europace · doi:10.1093/europace/euab184 · Cited by 22
Metadata
- Authors
- Brodsky, S. V., Nadasdy, T., Rovin, B. H., Satoskar, A. A., Nadasdy, G. M., Wu, H. M., Bhatt, U. Y., & Hebert, L. A.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 80
- Issue
- 2
- Pages
- 181-189
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2008493502
- Cited by
- 314
- References
- 13
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.